Literature DB >> 32113508

Looming threat of COVID-19 infection in Africa: act collectively, and fast.

John N Nkengasong1, Wessam Mankoula2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32113508      PMCID: PMC7124371          DOI: 10.1016/S0140-6736(20)30464-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
Because of the high volume of air traffic and trade between China and Africa, Africa is at a high risk for the introduction and spread of the novel coronavirus disease 2019 (COVID-19); although only Egypt has reported the first case, from a non-national. The greatest concern for public health experts is whether COVID-19 will become a pandemic, with sustained year-round transmission, similar to influenza, as is now being observed in several countries. What might happen to Africa—where most countries have weak health-care systems, including inadequate surveillance and laboratory capacity, scarcity of public health human resources, and limited financial means—if a pandemic occurs? With neither treatment nor vaccines, and without pre-existing immunity, the effect might be devastating because of the multiple health challenges the continent already faces: rapid population growth and increased movement of people; existing endemic diseases, such as human immunodeficiency virus, tuberculosis, and malaria; remerging and emerging infectious pathogens such as Ebola virus disease, Lassa haemorrhagic fever, and others; and increasing incidence of non-communicable diseases. Models that enable the continent to better allocate scarce resources to better prepare and respond to the COVID-19 epidemic are crucial. The modelling study by Marius Gilbert and colleagues in The Lancet identifies each African country's risk of importation of COVID-19 from China, using data on the volume of air travel from three airports in provinces in China to African countries. Gilbert and colleagues use two indicators to determine the capacity of countries to detect and respond to cases: preparedness, using the WHO International Health Regulations Monitoring and Evaluation Framework; and vulnerability, using the Infectious Disease Vulnerability Index. Based on their analysis, Egypt, Algeria, and South Africa had the highest importation risk, and a moderate to high capacity to respond to outbreaks. Nigeria, Ethiopia, Sudan, Angola, Tanzania, Ghana, and Kenya had moderate risk with variable capacity and high vulnerability. In the model, the risk mainly originates from Guangdong, Fujian, and Beijing. The study provides a valuable tool that can help countries in Africa prioritise and allocate resources as they prepare to respond to the potential introduction and spread of COVID-19. The study should also be interpreted in light of the fast-evolving nature of the COVID-19 outbreak. First, with the exception of Ethiopian airlines, all African airlines have suspended flights to China. Although these measures might delay, but not stop, the importation risk of COVID-19 into Africa, their implementation is still worthwhile. Second, although Beijing, Shanghai, and Fujian do not report the highest number of cases of COVID-19 in China, the volume of travel from these cities to Africa is high, which might increase the risk of exporting cases to Africa. Lastly, almost half of the flights from Africa to China are operated by Ethiopian Airlines, so it is possible that cases might pass through Ethiopia and affect destination countries. The report by Gilbert and colleagues provides an important tool to map out the continental risk for the spread of COVID-19 in Africa, which should be used to inform a framework of action to prepare the continent for any potential importation and spread of COVID-19. First, collectively, Africa needs a unified continent-wide strategy for preparedness and response. The strategy must be comprehensive, and member states, donors, and partners should immediately commit to releasing financial resources to support country-customised implementation plans derived from the strategy. To help develop a common strategy that will allow for effective coordination, collaboration, and communication, the African Union Commission, Africa Centres for Disease Control and Prevention (Africa CDC), and WHO, in partnership with African countries, have established the Africa Taskforce for Coronavirus Preparedness and Response (AFTCOR). The partnership has six work streams: laboratory diagnosis and subtyping; surveillance, including screening at points of entry and cross-border activities; infection prevention and control in health-care facilities; clinical management of people with severe COVID-19; risk communication; and supply-chain management and stockpiles. Because mitigating the potential spread of COVID-19 in Africa will require rapid detection and containment, the laboratory work streams of AFTCOR, Africa CDC, and WHO are working closely to expeditiously scale up diagnostic testing capacity linked to enhanced surveillance and monitoring—eg, at the beginning of February, only two countries in Africa had the diagnostic capacity to test for COVID-19. However, as of Feb 25, 2020, more than 40 countries would have been capacitated to accurately diagnose COVID-19 infection, thanks to the coordination efforts of AFTCOR. As testing becomes more available, it is possible that more cases might be detected. Second, any effective preparedness and response strategy for COVID-19 requires a committed political will; as such, the African Union Commission, Africa CDC, and WHO convened, on Feb 22, 2020, in Addis Ababa, Ethiopia, an emergency meeting of all ministers of health of 55 member states to commit to acting fast and collectively to develop and implement a coordinated continent-wide strategy. AFTCOR taskforce was formed, and a continent-wide strategy was endorsed at the end of the emergency meeting, with a call for strong coordination of efforts. To prevent the occurrence of a social, health security, and economic tragedy, actions agreed at the emergency ministerial meeting will need to be acted on quickly, before any additional COVID-19 cases are introduced to the continent, and result in sustained human-to-human transmission. The potential social, economic, and security devastation that COVID-19 could cause in Africa should be enough of an incentive for African governments to invest immediately in preparedness for the worst-case scenario. Third, commitment and release of financial resources from partners and donors before a crisis hits Africa will help anticipate demand and address supply chain management, mapping, and stockpiling of COVID-19 response needs, such as large quantities of personal protective equipment, gloves, surgical masks, coveralls, and hoods, and medical countermeasures like antiviral agents. Supplies of these items will be limited in Africa because of reduced manufacturing capacity. Fourth, national, regional, and international organisations need to cooperate and collaborate to optimise limited supplies, using a whole of government approach. Fifth, all member states will need to urgently develop and put in place proper quarantine and infection control protocols, including procedures for implementing social distancing (mass gathering and potential closure of public facilities). Lastly, the capacity-building training efforts that Africa CDC and WHO are conducting must be implemented and cascaded immediately down the health system pyramid in each country. Medical staff at major hospitals must be trained in the proper protocols of quarantining individuals who are at-risk of COVID-19 infection, as well as isolation and safe treatment of patients who test positive. As the Director General of WHO has stated several times, the window of opportunity to act is narrowing. Africa needs to be supported to act now, and needs to act fast.
  3 in total

1.  Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study.

Authors:  Marius Gilbert; Giulia Pullano; Francesco Pinotti; Eugenio Valdano; Chiara Poletto; Pierre-Yves Boëlle; Eric D'Ortenzio; Yazdan Yazdanpanah; Serge Paul Eholie; Mathias Altmann; Bernardo Gutierrez; Moritz U G Kraemer; Vittoria Colizza
Journal:  Lancet       Date:  2020-02-20       Impact factor: 79.321

2.  China's response to a novel coronavirus stands in stark contrast to the 2002 SARS outbreak response.

Authors:  John Nkengasong
Journal:  Nat Med       Date:  2020-03       Impact factor: 53.440

3.  The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak.

Authors:  Matteo Chinazzi; Jessica T Davis; Marco Ajelli; Corrado Gioannini; Maria Litvinova; Stefano Merler; Ana Pastore Y Piontti; Kunpeng Mu; Luca Rossi; Kaiyuan Sun; Cécile Viboud; Xinyue Xiong; Hongjie Yu; M Elizabeth Halloran; Ira M Longini; Alessandro Vespignani
Journal:  Science       Date:  2020-03-06       Impact factor: 47.728

  3 in total
  100 in total

Review 1.  COVID-19 in Africa: an ovarian victory?

Authors:  Osman A Dufailu; Afrakoma Afriyie-Asante; Bernard Gyan; David Adu Kwabena; Helena Yeboah; Frank Ntiakoh; Meshach Asare-Werehene
Journal:  J Ovarian Res       Date:  2021-05-21       Impact factor: 4.234

2.  Democracy and Mobility: A Preliminary Analysis of Global Adherence to Non-Pharmaceutical Interventions for COVID-19.

Authors:  Cristina M Herren; Tenley K Brownwright; Erin Y Liu; Nisrine El Amiri; Maimuna S Majumder
Journal:  SSRN       Date:  2020-04-07

Review 3.  Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future.

Authors:  Olayinka O Ogunleye; Debashis Basu; Debjani Mueller; Jacqueline Sneddon; R Andrew Seaton; Adesola F Yinka-Ogunleye; Joshua Wamboga; Nenad Miljković; Julius C Mwita; Godfrey Mutashambara Rwegerera; Amos Massele; Okwen Patrick; Loveline Lum Niba; Melaine Nsaikila; Wafaa M Rashed; Mohamed Ali Hussein; Rehab Hegazy; Adefolarin A Amu; Baffour Boaten Boahen-Boaten; Zinhle Matsebula; Prudence Gwebu; Bongani Chirigo; Nongabisa Mkhabela; Tenelisiwe Dlamini; Siphiwe Sithole; Sandile Malaza; Sikhumbuzo Dlamini; Daniel Afriyie; George Awuku Asare; Seth Kwabena Amponsah; Israel Sefah; Margaret Oluka; Anastasia N Guantai; Sylvia A Opanga; Tebello Violet Sarele; Refeletse Keabetsoe Mafisa; Ibrahim Chikowe; Felix Khuluza; Dan Kibuule; Francis Kalemeera; Mwangana Mubita; Joseph Fadare; Laurien Sibomana; Gwendoline Malegwale Ramokgopa; Carmen Whyte; Tshegofatso Maimela; Johannes Hugo; Johanna C Meyer; Natalie Schellack; Enos M Rampamba; Adel Visser; Abubakr Alfadl; Elfatih M Malik; Oliver Ombeva Malande; Aubrey C Kalungia; Chiluba Mwila; Trust Zaranyika; Blessmore Vimbai Chaibva; Ioana D Olaru; Nyasha Masuka; Janney Wale; Lenias Hwenda; Regina Kamoga; Ruaraidh Hill; Corrado Barbui; Tomasz Bochenek; Amanj Kurdi; Stephen Campbell; Antony P Martin; Thuy Nguyen Thi Phuong; Binh Nguyen Thanh; Brian Godman
Journal:  Front Pharmacol       Date:  2020-09-11       Impact factor: 5.810

4.  Predicting the effect of confinement on the COVID-19 spread using machine learning enriched with satellite air pollution observations.

Authors:  Xiaofan Xing; Yuankang Xiong; Ruipu Yang; Rong Wang; Weibing Wang; Haidong Kan; Tun Lu; Dongsheng Li; Junji Cao; Josep Peñuelas; Philippe Ciais; Nico Bauer; Olivier Boucher; Yves Balkanski; Didier Hauglustaine; Guy Brasseur; Lidia Morawska; Ivan A Janssens; Xiangrong Wang; Jordi Sardans; Yijing Wang; Yifei Deng; Lin Wang; Jianmin Chen; Xu Tang; Renhe Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-17       Impact factor: 11.205

5.  Protective Behaviors and Secondary Harms Resulting From Nonpharmaceutical Interventions During the COVID-19 Epidemic in South Africa: Multisite, Prospective Longitudinal Study.

Authors:  Guy Harling; Francesc Xavier Gómez-Olivé; Joseph Tlouyamma; Tinofa Mutevedzi; Chodziwadziwa Whiteson Kabudula; Ruth Mahlako; Urisha Singh; Daniel Ohene-Kwofie; Rose Buckland; Pedzisai Ndagurwa; Dickman Gareta; Resign Gunda; Thobeka Mngomezulu; Siyabonga Nxumalo; Emily B Wong; Kathleen Kahn; Mark J Siedner; Eric Maimela; Stephen Tollman; Mark Collinson; Kobus Herbst
Journal:  JMIR Public Health Surveill       Date:  2021-05-13

6.  The need for a balanced hospital-based care (HBC) and home- and community-based care (HCBC) approach for mitigating COVID-19 pandemic in sub-Saharan Africa.

Authors:  Harris Onywera; Lamech Malagho Mwapagha; Nei-Yuan Hsiao
Journal:  Pan Afr Med J       Date:  2021-02-22

7.  Psychological responses among nurses caring for patients with COVID-19: a comparative study in China.

Authors:  Honggang Ren; Xingguang Luo; Yincheng Wang; Xiaoyun Guo; Huiru Hou; Yong Zhang; Pengcheng Yang; Fang Zhu; Chao Hu; Runsheng Wang; Yu Sun; Yingzhen Du; Qin Yin; Guogang Xu; Hui Zuo; Qinyong Hu; Yahui Wang
Journal:  Transl Psychiatry       Date:  2021-05-06       Impact factor: 6.222

8.  Impact of Policy and Funding Decisions on COVID-19 Surveillance Operations and Case Reports - South Sudan, April 2020-February 2021.

Authors:  Talya Shragai; Aimee Summers; Olu Olushayo; John Rumunu; Valerie Mize; Richard Laku; Sudhir Bunga
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-06-04       Impact factor: 17.586

9.  Diagnostic performance of rapid antigen test for COVID-19 and the effect of viral load, sampling time, subject's clinical and laboratory parameters on test accuracy.

Authors:  Rania M Amer; Mohamed Samir; Osama A Gaber; Nahawand A El-Deeb; Ahmed A Abdelmoaty; Alshymaa A Ahmed; Walaa Samy; Amal H Atta; Mohammad Walaa; Reham H Anis
Journal:  J Infect Public Health       Date:  2021-06-11       Impact factor: 3.718

10.  The impact of COVID-19 control measures on social contacts and transmission in Kenyan informal settlements.

Authors:  Matthew Quaife; Kevin van Zandvoort; Amy Gimma; Kashvi Shah; Nicky McCreesh; Kiesha Prem; Edwine Barasa; Daniel Mwanga; Beth Kangwana; Jessie Pinchoff; W John Edmunds; Christopher I Jarvis; Karen Austrian
Journal:  BMC Med       Date:  2020-10-05       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.